ResearcherSecond Hospital of Tianjin Medical UniversityActive in the last 2 years
Zhijia Jiang
Matched on OpenAlex author ID A5110695305. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers
Papers 7
- Chemotherapy-associated mutational process signature and genomic alterations associated with outcome in metastatic pancreatic cancer. Co-author DOI 10.1007/s12094-025-03975-1↗
- Hypoxia- and lactate metabolism-associated prognostic and therapeutic signature in pancreatic cancer. Co-author DOI 10.1007/s12672-025-02873-w↗
- N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer. Co-author DOI 10.1080/21655979.2022.2088497↗
- Aspirin use and pancreatic cancer risk: A systematic review of observational studies. Co-author DOI 10.1097/md.0000000000018033↗
- Downregulation of miR-21 inhibits the malignant phenotype of pancreatic cancer cells by targeting VHL. First author DOI 10.2147/ott.s211535↗
- FOXO3a expression and its diagnostic value in pancreatic ductal adenocarcinoma. First author PMID 31949625↗
- Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized cont… Co-author DOI 10.1179/1973947815y.0000000013↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jinjin Sun · 6 shared papers, 2015–2025 · strength 0.91
- Paper Hypoxia- and lactate metabolism-associated prognostic and therapeutic signature in pancreatic cancer. DOI 10.1007/s12672-025-02873-w↗
- Paper Chemotherapy-associated mutational process signature and genomic alterations associated with outcome in metastatic panc… DOI 10.1007/s12094-025-03975-1↗
- Paper Aspirin use and pancreatic cancer risk: A systematic review of observational studies. DOI 10.1097/md.0000000000018033↗
- Yanxun Li · 4 shared papers, 2015–2022 · strength 0.49
- Paper N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cance… DOI 10.1080/21655979.2022.2088497↗
- Paper Aspirin use and pancreatic cancer risk: A systematic review of observational studies. DOI 10.1097/md.0000000000018033↗
- Paper Downregulation of miR-21 inhibits the malignant phenotype of pancreatic cancer cells by targeting VHL. DOI 10.2147/ott.s211535↗
- Kaiqiang Wang · 2 shared papers, 2019–2025 · strength 0.32
- Chenhui Zhang · 1 shared paper, 2025 · strength 0.30
- Hao Yao · 1 shared paper, 2025 · strength 0.30
- Geng Liu · 2 shared papers, 2018–2019 · strength 0.21
- Yaqing Wei · 1 shared paper, 2025 · strength 0.21
- Geng Liu · 2 shared papers, 2015–2019 · strength 0.19
- Jinjin Sun · 1 shared paper, 2022 · strength 0.19
- Dong Su Yu · 1 shared paper, 2018 · strength 0.10
- Shuang Feng · 1 shared paper, 2018 · strength 0.10
- Jun Li · 1 shared paper, 2018 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.